Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718512 | SCV001943956 | likely benign | not provided | 2020-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002073368 | SCV002464216 | likely benign | RASopathy | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002386505 | SCV002691144 | likely benign | Cardiovascular phenotype | 2021-12-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV002468289 | SCV002763473 | likely benign | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002468288 | SCV002763475 | likely benign | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing | ||
Fulgent Genetics, |
RCV002496041 | SCV002804352 | likely benign | Fibromatosis, gingival, 1; Noonan syndrome 4 | 2021-07-27 | criteria provided, single submitter | clinical testing |